Zhihai Ke | Chemistry | Innovative Research Award

Published on by China Scientist
Researcher Information
Affiliation The Chinese University of Hong Kong (Shenzhen)
Country China
Scopus ID 55658596800
Documents 52
Citations 1619
h-index 21
Subject Area Chemistry
Event China Scientist Awards
ORCID 0000-0001-7079-8845

Innovative Research Award

Zhihai Ke – The Chinese University of Hong Kong (Shenzhen)

Zhihai Ke is a researcher in chemistry whose scholarly contributions emphasize asymmetric catalysis, chalcogen-bonding catalysis, advanced functional materials, and electrochemical sensing technologies. His publications demonstrate interdisciplinary collaboration and sustained scientific productivity, supporting innovations relevant to modern chemical sciences and advanced materials research.[1]

Abstract

This article summarizes the academic profile of Zhihai Ke, highlighting notable contributions in asymmetric catalysis, chalcogen-bonding catalysis, and advanced electrochemical sensing materials. The overview reflects publication productivity, research influence, and scholarly impact in contemporary chemistry while considering suitability for recognition through the China Scientist Awards.[1]

Keywords

Asymmetric Catalysis, Chalcogen Bonding, Organic Chemistry, Electrochemistry, MXene, Nanomaterials, Electrochemical Sensors, Catalysis, Materials Chemistry, Sustainable Chemistry

Introduction

Zhihai Ke conducts research spanning synthetic organic chemistry, catalytic methodology, and functional nanomaterials. His investigations combine mechanistic understanding with practical applications, producing innovative catalytic systems and sensing technologies that contribute to chemical synthesis and analytical science while encouraging interdisciplinary scientific advancement.[1]

Research Profile

Affiliated with The Chinese University of Hong Kong (Shenzhen), Zhihai Ke has developed an active publication record supported by strong citation performance. His research portfolio emphasizes asymmetric catalysis, chalcogen-bond interactions, and advanced materials, demonstrating sustained contributions across multiple chemistry disciplines.[2]

Research Contributions

His work introduces efficient catalytic strategies, innovative reaction mechanisms, and functional nanostructured materials for sensing applications. These studies improve reaction selectivity, expand catalyst design principles, and enhance electrochemical detection performance, supporting continued advancement in synthetic chemistry and materials engineering.[2][3]

Publications

Published studies cover asymmetric bromoetherification, autotandem chalcogen-bonding catalysis, and MXene-based electrochemical sensors. These peer-reviewed articles demonstrate methodological innovation and interdisciplinary collaboration while contributing valuable knowledge to organic chemistry, catalysis, and materials science.[1][2][3]

Research Impact

The research has influenced catalytic methodology and advanced sensing technologies through highly cited publications and collaborative investigations. Its scientific relevance extends to synthetic chemistry, nanomaterials, and electrochemical analysis, encouraging future innovation and practical technological applications.[1][3]

Award Suitability

Based on publication quality, citation metrics, interdisciplinary research, and sustained scientific productivity, Zhihai Ke demonstrates attributes commonly associated with recognition by the China Scientist Awards. His contributions support scientific excellence, innovation, and international collaboration within contemporary chemical research.[1]

Conclusion

Zhihai Ke has established a distinguished research profile through innovative chemistry research, impactful publications, and interdisciplinary collaboration. His achievements in catalysis and advanced materials continue supporting scientific progress, making his academic contributions noteworthy within the international chemistry research community.[1][2]

External Links

References

  1. Electrostatically assembled MnO2 nanoflower-pillared Ti3C2Tx MXene heterostructures for flexible, high-sensitivity electrochemical sensors.
    https://www.sciencedirect.com/science/article/abs/pii/S2588842026000805
  2. Catalytic Asymmetric Bromoetherification and Desymmetrization of Olefinic 1,3‐Diols with C2‐Symmetric Sulfides.
    https://www.researchgate.net/publication/409408759_Catalytic_Asymmetric_Bromoetherification_and_Desymmetrization_of_Olefinic_13-Diols_with_C2-Symmetric_Sulfides
  3. Autotandem Chalcogen-Bonding Catalysis: Oxaselenolium-Catalyzed Cascade Povarov–Hydrogen-Transfer Reaction.
    https://www.researchgate.net/publication/395164505_Autotandem_Chalcogen-Bonding_Catalysis_Oxaselenolium-Catalyzed_Cascade_Povarov-Hydrogen-Transfer_Reaction

Jinming Zhou | Medicinal Chemistry | Best Researcher Award

Published on by China Scientist

Dr. Jinming Zhou | Medicinal Chemistry| Best Researcher Award

Research and Grant Success:

  • Dr. Zhou’s research has been consistently supported by prestigious National Natural Science Foundation (NCSF) grants, with four approvals to date. This grant success not only reflects the high quality and impact of his research but also indicates his capacity to conduct rigorous and relevant studies that address critical health challenges.
Dr. Jinming Zhou, Zhejiang Normal University , China

Profile

Scopus

OrcID

🌱EARLY ACADEMIC PURSUITS

  • Dr. Zhou’s academic journey began at Beijing Normal University, where he earned his Bachelor of Science (B.S.) in 2000 and Master of Science (M.S.) in 2003. His passion for rational drug design led him to pursue a Ph.D. at the Shanghai Institute of Organic Chemistry, where he specialized in this field, establishing a strong foundation in medicinal chemistry. Postdoctoral training followed at McGill University in Canada, where he continued advancing in rational drug design and gained international research exposure.

💼 PROFESSIONAL ENDEAVORS

  • In 2010, Dr. Zhou joined the Institute of Medicinal Biotechnology at the Chinese Academy of Medical Science as an Associate Professor. Demonstrating outstanding contributions in drug research, he achieved full professorship in 2017. His career took a new turn in 2018 when he accepted a professorship at Zhejiang Normal University, where he also became the Director of the Drug Development and Innovation Center. Dr. Zhou’s leadership at this center has been pivotal in establishing innovative practices and groundbreaking projects.

🔬CONTRIBUTIONS AND RESEARCH FOCUS 

  • Dr. Zhou’s research team is at the forefront of developing anti-viral and anti-cancer drugs. His group combines rational drug design and applied medicinal research to create effective therapeutic solutions. His work has a special emphasis on translational medicine, aiming to bridge scientific research and clinical applications. He has secured four prestigious National Natural Science Foundation (NCSF) grants, supporting his work in advancing therapeutic drug development.

📚ACADEMIC CITES 

  • With over a hundred publications, Dr. Zhou has significantly impacted medicinal chemistry, particularly in antiviral and anticancer drug design. His research has become a widely cited reference in related studies, underscoring his scientific contributions’ value and relevance.

🌍IMPACT AND INFLUENCE

  • Dr. Zhou’s influence in the medicinal chemistry field is highlighted by his 100+ publications in high-impact journals, showcasing the scientific community’s recognition of his expertise. His achievements were honored in 2012 with the prestigious “Xiehe Star” award, recognizing his exceptional contributions to the field of drug design.

🌟LEGACY AND FUTURE AND CONTRIBUTIONS

  • As Dr. Zhou continues his work at the Drug Development and Innovation Center, he is shaping a new generation of researchers focused on tackling global health challenges. His legacy is built not only on his published works but also on his mentorship and role in expanding the field of drug innovation. His ongoing research promises to further the understanding of rational drug design and its applications in combating complex diseases.

📄Publications

  • “Inducing or enhancing protein-protein interaction to develop drugs: Molecular glues with various biological activity”
    Authors: Zhang, R., Zheng, Y., Xiang, F., Zhou, J.
    Journal: European Journal of Medicinal Chemistry, 2024, 277, 116756
  • “METTL3 inhibitor suppresses the progression of prostate cancer via IGFBP3/AKT pathway and synergizes with PARP inhibitor”
    Authors: Chen, X., Wang, M., Wang, H., Zhou, J., Wu, M.
    Journal: Biomedicine and Pharmacotherapy, 2024, 179, 117366
  • “Autophagy mediated targeting degradation, a promising strategy in drug development”
    Authors: Zhang, J., Pan, X., Ji, W., Zhou, J.
    Journal: Bioorganic Chemistry, 2024, 149, 107466
  • “A novel hydrophobic tag leads to the efficient degradation of programmed death-ligand 1”
    Authors: Gao, J., Xie, Y., Zhang, J., Cen, S., Zhou, J.
    Journal: RSC Medicinal Chemistry, 2024, 15(9), pp. 3038–3047
  • “Design and Synthesis of Dual-Target Inhibitors Targeting Androgen Receptors and Glucocorticoid Receptors to Overcome Antiandrogen Resistance in Castration-Resistant Prostate Cancer”
    Authors: Li, C., Han, X., Yan, Q., Wu, M., Zhou, J.
    Journal: Journal of Medicinal Chemistry, 2024, 67(5), pp. 3419–3436